tiprankstipranks
Trending News
More News >

SSY Group Secures Approval for Sodium Bicarbonate Injection

Story Highlights
SSY Group Secures Approval for Sodium Bicarbonate Injection

Confident Investing Starts Here:

SSY Group ( (HK:2005) ) just unveiled an update.

SSY Group Limited has received approval from the National Medical Products Administration of China for the production and registration of Sodium Bicarbonate Injection in ampoule form. This development is significant as the drug is used in treating metabolic acidosis, alkalinization of urine, and intravenous intoxication by certain drugs, potentially enhancing the company’s market position and offering new treatment options.

More about SSY Group

SSY Group Limited operates in the pharmaceutical industry, focusing on the development and production of chemical drugs. The company is engaged in creating medical solutions, with a market focus on drug production and registration.

YTD Price Performance: -3.70%

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $1.24B

See more data about 2005 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App